Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Aditxt Inc
ADTX
Healthcare
Biotechnology
Aditxt, Inc., a commercial-stage company, discovers and develops products in the areas of immune health, precision health, population health, women’s health, and neurologic health. The company develops AditxtScore that enable individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a...
nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues. It also develops ADI-100 for skin grafting, psoriasis, type 1 diabetes, and multiple sclerosis. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Mountain View, California.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (NDAQ:ADTX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
Next
(0)
•••
PressRelease
X
Post by
PressRelease
on Dec 13, 2023 12:06pm
New Press Release - SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Aditxt, Inc. Merger
Wilmington, Delaware--(Newsfile Corp. - December 13, 2023) - Rigrodsky Law, P.A. is investigating Aditxt, Inc. ("Aditxt") (NASDAQ: ADTX) regarding possible breaches of fiduciary duties and other violations of law related to Aditxt's agreement to merge with Evofem Biosciences, Inc.To learn more...
read article.
(1069)
•••
Iseneschal
X
Post by
Iseneschal
on Dec 12, 2023 12:46pm
ADTX..... Looks like it's ready to break out to the upside
Me ....no position I do feel that EVFM will follow the up if ADTX break $7
(59)
•••
Nibinator
X
Post by
Nibinator
on Dec 12, 2023 10:16am
I dont know if momy let me stay for the after party
You did see it coming incredible!
(0)
•••
PressRelease
X
Post by
PressRelease
on Dec 12, 2023 9:53am
New Press Release - ADTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Aditxt, Inc. Is Fair to Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Aditxt, Inc. (NASDAQ: ADTX) and Evofem Biosciences, Inc. is fair to Aditxt shareholders. Halper Sadeh encourages Aditxt shareholders to click here to learn more about their legal rights and options or contact...
read article.
(1069)
•••
Iseneschal
X
Comment by
Iseneschal
on Dec 12, 2023 9:32am
RE:ADTX...... Wait for the fireworks...u ain't seen nothin yet
Merry Xmas comes early Yeeha!!!!
(0)
•••
PressRelease
X
Post by
PressRelease
on Dec 12, 2023 8:32am
New Press Release - Aditxt, Inc. Enters into Definitive Agreement to Acquire Evofem Biosciences, Inc., Creator of Phexxi®, the First and Only FDA-Approved Hormone-Free Contraceptive Gel, to Address Diverse Reproductive Health Needs of Women Globally
Evofem posted $13.4 million in net sales of Phexxifor the first nine months of 2023;Aditxt looks to accelerate Evofem into the global non-hormonal birth control market valued at $27.7 billion in 2022 and is projected to grow to $52.2 billion by 2031 Aditxt, Inc. (“Aditxt” or the “Company...
read article.
(1069)
•••
Iseneschal
X
Post by
Iseneschal
on Dec 07, 2023 11:02am
ADTX ...got to $4.10 then backed off
Ho hum......wait fot the pump and volume to increase Not today tho
(1069)
•••
Iseneschal
X
Post by
Iseneschal
on Dec 07, 2023 10:58am
ADTX...... Wait for the fireworks...u ain't seen nothin yet
JMHO
(1069)
•••
Iseneschal
X
Post by
Iseneschal
on Dec 07, 2023 10:52am
ADTX....gettiing some low volume love & price action
Chit will hit the fan if sh price breaks $4.10
(1069)
•••
Iseneschal
X
Post by
Iseneschal
on Dec 04, 2023 12:13pm
ADTX...if it looks like a slimey slug.....
it is !!!!!!!!!!!!!!!!!
(1069)
•••
Iseneschal
X
Post by
Iseneschal
on Nov 30, 2023 8:33am
ADTX....early a.m runner on no news
On watch
(1069)
•••
Iseneschal
X
Post by
Iseneschal
on Apr 21, 2023 9:30am
ADTX...... This has got to be the "Slimiest" deal going
Do some research.....read every word printed.....time it with the share price and volume.....you will see what I mean. What pile !!!!!!!!!!!!!!!
(1069)
•••
Iseneschal
X
Post by
Iseneschal
on Jan 03, 2023 3:40pm
ADTX .... Scalped !
What a day !!!!
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 21, 2022 9:02am
New Press Release - Aditxt's (Nasdaq: ADTX) Adimune(TM) Program Has Initiated the Manufacturing Process of Immunotherapeutic Drug Candidate, ADI(TM)-100 in Preparation for Planned Psoriasis First-in-Human Trials
Aditxt, Inc. (Nasdaq: ADTX) (“Aditxt” or the “Company”), a biotech innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announces that its program Adimune™ has initiated the GMP manufacturing of drug candidate ADI™-100...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 12, 2022 9:12am
New Press Release - Aditxt, Inc. (Nasdaq: ADTX) Announces Development and Publication of a Mathematical Model for Predicting Longevity and Variations of Immune Response to Immunization to SARS-CoV-2 Infection
Results from the study evaluating AditxtScore™ for neutralizing antibodies (“NAb”) were published in the Journal of Theoretical Biology Aditxt, Inc. (Nasdaq: ADTX) (“Aditxt” or the “Company”), a biotech innovation company developing and commercializing technologies with a focus on monitoring and...
read article.
Prev
1
2
3
4
5
6
7
8
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
TomaGold Initiates Major Phase 2 Program at Berrigan Mine to Test Berrigan Deep Potential
Alvopetro 2025 Year End Reserves Includes a 79% Increase in Reserves & Replacement Ratio of 530%
Sorrento Resources Identifies Several High-Grade Soil Gold Anomalies up to 525m by 450m in Size, Newfoundland
Tungsten has quietly become one of the most strategic metals on the planet
Podcasts